Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Faivre

Showing results (21-30 of 64) with videos related to

Pageof 7
Sort By:
Anti-Cancer Drugs|August 1, 1997
Paclitaxel (Taxol)-associated junctional tachycardiaS Faivre, F Goldwasser, P Soulié, et al.
Seminars in Oncology|June 3, 1998
Oxaliplatin: mechanism of action and antineoplastic activityE Raymond, S Faivre, J M Woynarowski, et al.
Cancer Metastasis Reviews|January 24, 2014
Pancreatic NETs: where do we stand now?S Faivre, D Castellano, J Strosberg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2002
End points for new agents in induction chemotherapy for locally advanced head and neck cancersC Monnerat, S Faivre, S Temam, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 22, 2020
Medical oncologists must get more involved in systemic treatmentJ L Raoul, S Faivre, J S Frenel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 26, 2018
Medical oncologists must get more involved in systemic treatment of hepatocellular carcinomaJ L Raoul, S Faivre, J S Frenel, et al.
Bulletin Du Cancer|September 25, 2001
[Preclinical studies of oxaliplatin in combination chemotherapy]E Raymond, S Faivre, A M Coudray, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Activity of oxaliplatin against human tumor colony-forming unitsE Raymond, R Lawrence, E Izbicka, et al.
Chirurgie De La Main|July 16, 2002
[Rupture of the radial collateral ligament of the fifth metacarpopharyngeal joint. A case report with Stener effect]S Faivre, Y Bellumore, P Mansat, et al.
Critical Reviews in Oncology/Hematology|March 6, 2017
Understanding c-MET signalling in squamous cell carcinoma of the head & neckP Szturz, E Raymond, C Abitbol, et al.
Pageof 7

Showing results (21-30 of 64) with videos related to

Sort By:
Pageof 7
Anti-Cancer Drugs|August 1, 1997
Paclitaxel (Taxol)-associated junctional tachycardiaS Faivre, F Goldwasser, P Soulié, et al.
Seminars in Oncology|June 3, 1998
Oxaliplatin: mechanism of action and antineoplastic activityE Raymond, S Faivre, J M Woynarowski, et al.
Cancer Metastasis Reviews|January 24, 2014
Pancreatic NETs: where do we stand now?S Faivre, D Castellano, J Strosberg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2002
End points for new agents in induction chemotherapy for locally advanced head and neck cancersC Monnerat, S Faivre, S Temam, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 22, 2020
Medical oncologists must get more involved in systemic treatmentJ L Raoul, S Faivre, J S Frenel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 26, 2018
Medical oncologists must get more involved in systemic treatment of hepatocellular carcinomaJ L Raoul, S Faivre, J S Frenel, et al.
Bulletin Du Cancer|September 25, 2001
[Preclinical studies of oxaliplatin in combination chemotherapy]E Raymond, S Faivre, A M Coudray, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Activity of oxaliplatin against human tumor colony-forming unitsE Raymond, R Lawrence, E Izbicka, et al.
Chirurgie De La Main|July 16, 2002
[Rupture of the radial collateral ligament of the fifth metacarpopharyngeal joint. A case report with Stener effect]S Faivre, Y Bellumore, P Mansat, et al.
Critical Reviews in Oncology/Hematology|March 6, 2017
Understanding c-MET signalling in squamous cell carcinoma of the head & neckP Szturz, E Raymond, C Abitbol, et al.
Pageof 7